UroPROTECT
Natural health product licensed in Canada
- Other names
- UroDEFENCE
- Licence holder
- Canpower health inc.
- NPN or DIN-HM
- 80150319
- Status
- Active licence
- Licence date
- 12 August 2026
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phyllanthus niruri Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| Agathosma betulina Source : Agathosma betulina - Feuille | 50 mg | Not calculated |
| Arctostaphylos uva-ursi Source : Arctostaphylos uva-ursi - feuille | 300 mg | Not calculated |
| Althaea officinalis | 40 mg | Not calculated |
| Juniperus communis Source : Juniperus communis - Fruit | 10 mg | Not calculated |
| Petroselinum crispum Source : Petroselinum crispum - herb top | 50 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Cellulose microcristalline, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Arctostaphylos uva-ursi is traditionally used in Herbal Medicine as a mild diuretic to help relieve symptoms associated with minor urinary tract infections, such as burning sensation and/or frequent urination. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80150319
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.